Multiple Real-World Data Sources in a Bayesian Framework to Inform Long-Term Survival Estimates of Mosunetuzumab in Patients with Follicular Lymphoma

INTRODUCTION: Patients with follicular lymphoma (FL) receiving third-line or later (3L +) therapy have long survival, which can make estimating long-term overall survival (OS) from trial data challenging. The objective of this study was to estimate long-term OS for mosunetuzumab from the GO29781 tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanchez Alvarez, Javier, Jaber, Mahmoud, Blanchet Zumofen, Marie-Hélène
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673801/
https://www.ncbi.nlm.nih.gov/pubmed/37851321
http://dx.doi.org/10.1007/s40487-023-00245-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673801/
https://www.ncbi.nlm.nih.gov/pubmed/37851321
http://dx.doi.org/10.1007/s40487-023-00245-4

Ejemplares similares